Opportunity

SAM #W81K0026QA201

Ambulatory Multitherapy Infusion Pumps and Accessories for WBAMC Hematology/Oncology

Buyer

W40M Medical Materiel Center-West

Posted

June 23, 2026

Respond By

June 29, 2026

Identifier

W81K0026QA201

NAICS

339112

This procurement opportunity is for ambulatory multitherapy infusion pumps and accessories to support chemotherapy patients at William Beaumont Army Medical Center (WBAMC). - Government Buyer: - Department of Defense, U.S. Army Medical Readiness Command Office West - Sub-agency: William Beaumont Army Medical Center, Department of Hematology/Oncology - Products Requested: - 10 FDA-approved multitherapy ambulatory infusion pumps for home chemotherapy - Accessories include: - 2 rechargeable battery packs - 1 pack of 10 single-use pump pouches - 10 pump pouches (50-100 ML) - 10 pump pouches with waist belts (250-500 ML) - Pumps must feature intravenous delivery, linear peristaltic mechanism, alarms, dose error reduction, transportability (2-3 lbs), adjustable flow rates, proprietary cassette/IV bag reservoir, event log, security features, and compatibility with central lines - Includes two operator/user manuals and reprocessing instructions - Services Requested: - Onsite training for three nurses on pump operation - Separate quote for five-year service contract - Unique Requirements: - Delivery within 30 days of contract award; installation within five business days - No partial deliveries; delivery during business hours only - Pumps must be FDA-approved and suitable for home use - Training and manuals required for clinical staff - No specific OEMs or brands are named; opportunity is open to all qualified vendors - Small business set-aside under NAICS code 339112 - Estimated contract value likely ranges from $50,000 to $150,000 based on typical pricing for infusion pumps and accessories

Description

The requirement is for ten (10) ambulatory infusion pumps in support of the Department of Hematology/Oncology at WBAMC. Ambulatory pumps are vital for the continuous infusion of chemotherapy to patients from the comfort of their home, while also supporting patient mobility and reducing clinician visits.

View original listing